Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes
Acute lymphoblastic leukemia (ALL) is the most common type of malignant neoplasms in the pediatric population. B-cell precursor ALLs (BCP-ALLs) are derived from the progenitors of B lymphocytes. Traditionally, risk factors stratifying therapy in ALL patients included age at diagnosis, initial leukoc...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b23478871ab340618ebc3930ee9d4788 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b23478871ab340618ebc3930ee9d4788 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b23478871ab340618ebc3930ee9d47882021-11-11T15:33:40ZTowards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes10.3390/cancers132154832072-6694https://doaj.org/article/b23478871ab340618ebc3930ee9d47882021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5483https://doaj.org/toc/2072-6694Acute lymphoblastic leukemia (ALL) is the most common type of malignant neoplasms in the pediatric population. B-cell precursor ALLs (BCP-ALLs) are derived from the progenitors of B lymphocytes. Traditionally, risk factors stratifying therapy in ALL patients included age at diagnosis, initial leukocytosis, and the response to chemotherapy. Currently, treatment intensity is modified according to the presence of specific gene alterations in the leukemic genome. Raman imaging is a promising diagnostic tool, which enables the molecular characterization of cells and differentiation of subtypes of leukemia in clinical samples. This study aimed to characterize and distinguish cells isolated from the bone marrow of patients suffering from three subtypes of BCP-ALL, defined by gene rearrangements, i.e., <i>BCR-ABL1</i> <i>(Philadelphia</i>-positive, t(9;22)), <i>TEL-AML1</i> (t(12;21)) and <i>TCF3-PBX1</i> (t(1;19)), using single-cell Raman imaging combined with multivariate statistical analysis. Spectra collected from clinical samples were compared with single-cell spectra of B-cells collected from healthy donors, constituting the control group. We demonstrated that Raman spectra of normal B cells strongly differ from spectra of their malignant counterparts, especially in the intensity of bands, which can be assigned to nucleic acids. We also showed that the identification of leukemia subtypes could be automated with the use of chemometric methods. Results prove the clinical suitability of Raman imaging for the identification of spectroscopic markers characterizing leukemia cells.Patrycja LeszczenkoAleksandra Borek-DoroszAnna Maria NowakowskaAdriana AdamczykSviatlana KashyrskayaJustyna JakubowskaMarta ZąbczyńskaAgata PastorczakKinga OstrowskaMalgorzata BaranskaKatarzyna Maria MarzecKatarzyna MajznerMDPI AGarticleRaman spectroscopyacute lymphoblastic leukemia (ALL)fusion geneschemometric techniques<i>BCR-ABL1</i><i>TCF-PBX1</i>Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5483, p 5483 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Raman spectroscopy acute lymphoblastic leukemia (ALL) fusion genes chemometric techniques <i>BCR-ABL1</i> <i>TCF-PBX1</i> Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Raman spectroscopy acute lymphoblastic leukemia (ALL) fusion genes chemometric techniques <i>BCR-ABL1</i> <i>TCF-PBX1</i> Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Patrycja Leszczenko Aleksandra Borek-Dorosz Anna Maria Nowakowska Adriana Adamczyk Sviatlana Kashyrskaya Justyna Jakubowska Marta Ząbczyńska Agata Pastorczak Kinga Ostrowska Malgorzata Baranska Katarzyna Maria Marzec Katarzyna Majzner Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes |
description |
Acute lymphoblastic leukemia (ALL) is the most common type of malignant neoplasms in the pediatric population. B-cell precursor ALLs (BCP-ALLs) are derived from the progenitors of B lymphocytes. Traditionally, risk factors stratifying therapy in ALL patients included age at diagnosis, initial leukocytosis, and the response to chemotherapy. Currently, treatment intensity is modified according to the presence of specific gene alterations in the leukemic genome. Raman imaging is a promising diagnostic tool, which enables the molecular characterization of cells and differentiation of subtypes of leukemia in clinical samples. This study aimed to characterize and distinguish cells isolated from the bone marrow of patients suffering from three subtypes of BCP-ALL, defined by gene rearrangements, i.e., <i>BCR-ABL1</i> <i>(Philadelphia</i>-positive, t(9;22)), <i>TEL-AML1</i> (t(12;21)) and <i>TCF3-PBX1</i> (t(1;19)), using single-cell Raman imaging combined with multivariate statistical analysis. Spectra collected from clinical samples were compared with single-cell spectra of B-cells collected from healthy donors, constituting the control group. We demonstrated that Raman spectra of normal B cells strongly differ from spectra of their malignant counterparts, especially in the intensity of bands, which can be assigned to nucleic acids. We also showed that the identification of leukemia subtypes could be automated with the use of chemometric methods. Results prove the clinical suitability of Raman imaging for the identification of spectroscopic markers characterizing leukemia cells. |
format |
article |
author |
Patrycja Leszczenko Aleksandra Borek-Dorosz Anna Maria Nowakowska Adriana Adamczyk Sviatlana Kashyrskaya Justyna Jakubowska Marta Ząbczyńska Agata Pastorczak Kinga Ostrowska Malgorzata Baranska Katarzyna Maria Marzec Katarzyna Majzner |
author_facet |
Patrycja Leszczenko Aleksandra Borek-Dorosz Anna Maria Nowakowska Adriana Adamczyk Sviatlana Kashyrskaya Justyna Jakubowska Marta Ząbczyńska Agata Pastorczak Kinga Ostrowska Malgorzata Baranska Katarzyna Maria Marzec Katarzyna Majzner |
author_sort |
Patrycja Leszczenko |
title |
Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes |
title_short |
Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes |
title_full |
Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes |
title_fullStr |
Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes |
title_full_unstemmed |
Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes |
title_sort |
towards raman-based screening of acute lymphoblastic leukemia-type b (b-all) subtypes |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/b23478871ab340618ebc3930ee9d4788 |
work_keys_str_mv |
AT patrycjaleszczenko towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes AT aleksandraborekdorosz towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes AT annamarianowakowska towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes AT adrianaadamczyk towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes AT sviatlanakashyrskaya towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes AT justynajakubowska towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes AT martazabczynska towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes AT agatapastorczak towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes AT kingaostrowska towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes AT malgorzatabaranska towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes AT katarzynamariamarzec towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes AT katarzynamajzner towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes |
_version_ |
1718435205494079488 |